Chief Executive Officer Alessandro Riva, M.D., To Leave Ichnos Sciences
Share this article Share this article NEW YORK, May 21, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today announced that Alessandro Riva, M.D., will be leaving Ichnos effective August 15, 2021. We want to thank Dr. Riva for his visionary leadership as the first CEO of Ichnos. His strategic and scientific drive have given Ichnos a solid foundation to create and develop new medicines for patients. We wish him well in his future endeavors. Effective immediately, Cyril Konto, M.D., is ap...
Source: prnewswire.com